Journal List > J Korean Soc Transplant > v.23(3) > 1034295

J Korean Soc Transplant. 2009 Dec;23(3):237-243. Korean.
Published online December 31, 2009.
Copyright © 2009 The Korean Society for Transplantation
The Risk Factors of Acute Cellular Rejection in Adult Living Donor Liver Transplantation: Doubting the Value of Positive Lymphocytotoxic Cross-match Results
Kyung Uk Jung, M.D., Jae Berm Park, M.D., Jong Man Kim, M.D., Ju Ik Moon, M.D., Gum O Jung, M.D., Jae Min Chun, M.D., Gyu-Seong Choi, M.D., Choon Hyuck David Kwon, M.D., Sung-Joo Kim, M.D., Jae-Won Joh, M.D., and Suk-Koo Lee, M.D.
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Corresponding author (Email: )
Received July 30, 2009; Accepted October 14, 2009.



The influence of lymphocytotoxic cross-match results on acute cellular rejection in adult living donor liver transplantation (LDLT) has not been well examined. Therefore, in this study, we investigated the risk factors of acute rejection, including positive lymphocytotoxic cross-match results.


Patients inquired in this study are adults who underwent their first LDLT between June 1997 and June 2007 (n=382). We reviewed retrospectively the medical records of donors and recipients, including medical history, surgical procedures, and progress, then analyzed the risk factors of acute rejection using Cox's proportion hazard model.


Among the total subjects of 382, 32 recipients had positive lymphocytotoxic cross-match results. Median follow-up duration was 28.0 months (range, 1~93). Fifty six recipients had suffered at least one or more acute rejection episodes. In univariate analysis, positive lymphocytotoxic cross-match results didn't turn out to be a significant risk factor of acute rejection (p=0.735), while recipient age (P=0.012), HCV-related (P=0.001), MELD score (P=0.042), gender mismatch (P=0.001) and no induction of anti-IL-2 receptor antibody (P=0.034) were revealed as risk factors for acute rejection. Recipient age (P=0.001, Hazard Ratio 0.937, 95% Confidence Interval 0.902~0.973), gender mismatch (P=0.001, Hazard Ratio 2.970, 95% Confidence Interval 1.524~5.788), HCV-related (P=0.001, Hazard Ratio 4.313, 95% Confidence Interval 1.786~10.417) were considered as significant risk factors in multivariate analysis.


Positive lymphocytotoxic cross-match results may not be the risk factor for acute rejection. Therefore, it should not be considered as a determinant when matching donors with recipients in adult LDLT.

Keywords: Human leukocyte antigen; Lymphocytotoxic cross-match; Acute rejection; Liver transplantation; Living donors


Fig. 1
Kaplan-Meier rejection-free survival curve of liver transplantations done in the negative (n=350) or positive (n=32) lym - phocytotoxic cross-match. There is no difference in the results (P=0.735).

Abbreviation: LCCM, lymphocytotoxic cross-match.

Click for larger image


Table 1
The characteristics of the living donor liver transplantation recipients (n=382)
Click for larger image

Table 2
Demographic findings and acute rejection rate in positive and negative cross-matches
Click for larger image

Table 3
FK506 level in positive and negative cross-matches
Click for larger image

Table 4
Risk factors for acute rejection in living donor liver transplantation recipients in the univariate analysis
Click for larger image

Table 5
Risk factors for acute rejection in living donor liver transplantation recipients in the multivariate analysis
Click for larger image

1. Sugawara Y, Makuuchi M. Technical advances in living-related liver transplantation. J Hepatobiliary Pancreat Surg 1999;6:245–253.
2. Takiff H, Cook DJ, Himaya NS, Mickey MR, Terasaki PI. Dominant effect of histocompatibility on ten-year kidney transplant survival. Transplantation 1988;45:410–415.
3. Zmijewski CM. Human leukocyte antigen matching in renal transplantation: review and current status. J Surg Res 1985;38:66–87.
4. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997;25:658–663.
5. Gordon RD, Fung JJ, Markus B, Fox I, Iwatsuki S, Esquivel CO, et al. The antibody crossmatch in liver transplantation. Surgery 1986;100:705–715.
6. Suh KS, Kim SB, Chang SH, Kim SH, Minn KW, Park MH, et al. Significance of positive cytotoxic cross-match in adult-to-adult living donor liver transplantation using small graft volume. Liver Transpl 2002;8:1109–1113.
7. Kim YD, Lee SG, Hwang S, Park KM, Kim KH, Ahn CS, et al. Analysis of relationship between positive T lymphocytotoxic and/or B lymphcytotoxic cross-match and acute rejection in adult-to-adult living donor liver transplantation. J Korean Soc Transplant 2004;18:183–187.
8. Demetris AJ, Markus BH. Immunopathology of liver transplantation. Crit Rev Immunol 1989;9:67–92.
9. Kerman RH. The role of crossmatching in organ transplantation. Arch Pathol Lab Med 1991;115:255–259.
10. Payne R, Rolfs MR. Fetomaternal leukocyte incompatibility. J Clin Invest 1958;37:1756–1763.
11. Van Rood JJ, Eernisse JG, Van Leeuwen A. Leucocyte antibodies in sera from pregnant women. Nature 1958;181:1735–1736.
12. Brooks BK, Levy MF, Jennings LW, Abbasoglu O, Vodapally M, Goldstein RM, et al. Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation 1996;62:1784–1787.
13. Charco R, Vargas V, Balsells J, Lázaro JL, Murio E, Jaurrieta E, et al. Influence of anti-HLA antibodies and positive T-lymphocytotoxic crossmatch on survival and graft rejection in human liver transplantation. J Hepatol 1996;24:452–459.
14. Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman RK, et al. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998;28:638–645.
15. Takakura K, Kiuchi T, Kasahara M, Uryuhara K, Uemoto S, Inomata Y, et al. Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation. Clin Transplant 2001;15:309–316.
16. Takaya S, Bronsther O, Iwaki Y, Nakamura K, Abu-Elmagd K, Yagihashi A, et al. The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 1992;53:400–406.

Jae-Won Joh

Similar articles

The effect of a positive T-lymphocytotoxic crossmatch on clinical outcomes in adult-to-adult living donor liver transplantation

Preoperative Selective Desensitization of Live Donor Liver Transplant Recipients Considering the Degree of T Lymphocyte Cross-Match Titer, Model for End-Stage Liver Disease Score, and Graft Liver Volume

Case Report of Kidney Paired Donation (KPD) with Desensitization: the Strategy and Experience of 3-Way KPD in Samsung Medical Center

Liver retransplantation for adult recipients

Donor Specific Antibody Negative Antibody-Mediated Rejection after ABO Incompatible Liver Transplantation